newsfilter
← Latest News
GlobeNewswire·

BioCardia Regains Compliance with Nasdaq Listing Requirements

SUNNYVALE, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has